scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF00294434 |
P698 | PubMed publication ID | 1792867 |
P2093 | author name string | D M Mann | |
P2860 | cites work | Cortical neuronal counts in normal elderly controls and demented patients. | Q53198437 |
A quantitative study of cerebral atrophy in old age and senile dementia | Q53199050 | ||
Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. | Q53301879 | ||
Alzheimer's disease: a correlative study | Q33621991 | ||
Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: measurements with an image analyser | Q34285836 | ||
Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease | Q35816172 | ||
Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease | Q37546301 | ||
Variations in the size of the human brain. Influence of age, sex, body length, body mass index, alcoholism, Alzheimer changes, and cerebral atherosclerosis. | Q39819256 | ||
Cortical atrophy in senile dementia of the Alzheimer type is mainly due to a decrease in cortical length | Q41497866 | ||
Regional weight loss of the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type | Q47185264 | ||
Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging | Q48224595 | ||
Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia | Q48305999 | ||
Positron emission tomography in Alzheimer's disease | Q48328045 | ||
A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. | Q48367859 | ||
Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. | Q48476318 | ||
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia | Q48719942 | ||
Alzheimer's disease: focal cortical changes shown by positron emission tomography | Q48768559 | ||
Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose | Q48768629 | ||
Demonstration of neurofibrillary tangles in paraffin sections: a quick and simple method using a modification of Palmgren's method | Q49118761 | ||
A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques | Q49121132 | ||
White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. | Q53191831 | ||
P433 | issue | 1 | |
P921 | main subject | Alzheimer's disease | Q11081 |
P304 | page(s) | 81-86 | |
P577 | publication date | 1991-01-01 | |
P1433 | published in | Acta Neuropathologica | Q343168 |
P1476 | title | The topographic distribution of brain atrophy in Alzheimer's disease | |
P478 | volume | 83 |
Q36317908 | A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? |
Q38837300 | An MRI study of age-related changes in the dimensions related temporal lobe |
Q40766817 | Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease |
Q38253639 | Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms |
Q34245589 | CLADA: cortical longitudinal atrophy detection algorithm |
Q48110604 | Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia |
Q45294222 | Clinical presentation and patterns of regional cerebral atrophy related to the length of trinucleotide repeat expansion in patients with adult onset Huntington's disease |
Q48636403 | Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. |
Q35450021 | Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia |
Q45291818 | Evidence for progression in frontal cortical pathology in late-stage Huntington's disease |
Q43668221 | Hippocampal formation glucose metabolism and volume losses in MCI and AD. |
Q59542878 | Hippocampus and entorhinal cortex in mild cognitive impairment and early AD |
Q48119453 | Human striatum: Chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease |
Q52029165 | Medial temporal atrophy and memory impairment in early stage of Alzheimer's disease: an MRI volumetric and memory assessment study. |
Q36316973 | Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study |
Q41460468 | Multimodal analysis of functional and structural disconnection in Alzheimer's disease using multiple kernel SVM. |
Q44410457 | Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease |
Q33609644 | Plasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome |
Q41875197 | RAM disease and other musings |
Q48214660 | Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease |
Q47212309 | Size of neocortical neurons in control subjects and in Alzheimer's disease |
Q40901287 | Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. |
Q38449896 | Specific temporoparietal gyral atrophy reflects the pattern of language dissolution in Alzheimer's disease. |
Q38462615 | The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. |
Q26777969 | The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease |
Q45291302 | The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. |
Q53202187 | The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease. |
Q48354838 | The topographic distribution of brain atrophy in frontal lobe dementia |
Q48124579 | Topography of callosal atrophy reflects distribution of regional cerebral volume reduction in Alzheimer's disease |
Q51939644 | Usefulness of a cube-copying test in outpatients with dementia. |
Q51023576 | Volume reduction in subcortical regions according to severity of Alzheimer's disease. |
Search more.